San Diego-centered Viking Therapeutics marked by itself as a significant competitor while in the weight loss drug current market in February just after revealing promising info from the mid-phase demo of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when offered for a weekly injection and in March t